Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.5000 (3.87%) ($14.0100 - $14.7600) on Wed. Oct. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 37 | Latest Price | $14.5000(3.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.92% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-10%) UUP(-8%) DRIV(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
5 Day Moving Average | $13.69(5.92%) | 10 Day Moving Average | $13.33(8.78%) | 20 Day Moving Average | $14.09(2.91%) | To recent high | -8.6% | To recent low | 21.6% | Market Cap | $1.077b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |